The global hydrophilic coatings market share will grow at a notable rate over 2021-2027 with increasing demand from automotive, medical, aerospace and marine applications. These coatings help in the reduction of surface friction and act like microscopic sponges. Hydrophilic molecules are ionic and polar, making them abrasion-resistant, biocompatible, lubricous and nonthrombogenic.
Hydrophilic coatings provide a low friction coefficient, low particulate count with increased durability. They can prevent protein adsorption and are highly sought-after in the medical industry for coating medical devices, especially surgical tools. Surfaces coated with the hydrophilic coating provide low pulling forces and can navigate anatomical pathways.
In terms of substrate, hydrophilic coatings market share from the nanoparticles segment will grow at a robust CAGR through 2027. The trend for nanomaterials and nanotechnology is mainly attributed to their biomedical, optical, electronic and physical properties. The use of silica nanoparticles, for instance, has gained prominence for producing super-hydrophilic, transparent and durable coatings on painted surfaces.
Based on application, the medical segment will garner substantial gain during the forecast period 2021-2027. Hydrophilic coating technologies create water-attracting surfaces, minimize the risk of damage to blood vessel walls and enable navigation in tortuous vascular pathways. The coating has expanded the range of treatment sites for neurological interventions, balloon catheter angioplasty and site-delivered drug therapies. The global hydrophilic coatings market growth will be triggered by increased demand for advanced medical techniques and lubricious medical devices.
The automotive application segment will witness moderate growth with increasing utilization of metals, polymers and glass substrates. Notably, hydrophilic coatings are applied to the glass of the mirrors, windshield and vehicle body. Tier one companies are likely to boost their production facilities that will further escalate the demand for hydrophilic coatings.
On the regional front, North America hydrophilic coatings market revenue is poised to grow with soaring demand for medical devices. The U.S. is expected to hold a competitive advantage in the medical device sector following the innovations in implantable medical devices. Notably, medical devices such as guidewires, intravascular catheters, balloon angioplasty catheters, implant delivery systems and delivery sheaths demand hydrophilic coatings. Moreover, a rise in hospital projects has encouraged companies to invest in critical medical components.
The competitiveness in the hydrophilic coatings industry has increased with product launches, collaboration, partnerships and mergers & acquisitions. Industry participants include Telefax Inc., Koninklijke DSM, BioInteractions Inc., Aculon, Surface Solution Group and Surmodics, among others. Surface Solution Group had launched low-friction and functional coatings for the medical sector. DSM has introduced hydrophilic coatings for implantable medical and disposable devices such as catheters, guidewires, neurological, vascular, ophthalmic and urinary applications.
Influence of the COVID-19 pandemic on global hydrophilic coatings market outlook
Hydrophilic coatings have gained profound traction amidst the rise of the COVID-19 pandemic. Some hydrophilic coating suppliers expanded their share in medical coatings. The strategic shift is primarily attributed to a dip in automotive production and loss across the aviation sector in 2020. The use of hydrophilic coatings has witnessed an increased demand for medical instruments, surgical tools and devices. The growth in the application of hydrophilic coatings was driven by the medical sector to some extent during the COVID-19 era.
The U.S. FDA has intensified its focus on medical device coatings to develop a framework, which will impact medical device companies and hydrophilic coating providers. Coating manufacturers are expected to create technologies that can be in line with rigorous quality control methods and biocompatible to enhance the performance of medical devices.